// App-Quantinova.ai

579 : Novel Cognitive Markers for Early Diagnosis and Monitoring of Progressive Supranuclear Palsy

Researchers

Presenter

  • M. Brzezicki

Principal Investigators

  • C. Antoniades

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Progressive supranuclear palsy

  • Parkinson's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A